Adenosine spares platelets during cardiopulmonary bypass in man without causing systemic vasodilatation.

The effect of infusing adenosine during cardiopulmonary bypass (CPB) on platelet count and mean arterial blood pressure (MABP) was studied in 13 patients (age 42-74), with 12 patients (age 47-66) as controls. Adenosine infusion (0.1 mg/kg/min in a central vein) caused a ten- to twentyfold increase of the adenosine concentration in the venous blood to the oxygenator, while the arterial levels were close to basal values (0.3 +/- 0.1 microM). The platelet count was significantly higher in the treated than in the placebo group during and 30 min after CPB, but not on the postoperative day. The groups did not differ with regard to the postoperative blood loss from tube drainage. Adenosine did not cause major systemic vasodilation (MABP less than 30 mmHg) in any case, and the blood pressure levels showed no intergroup difference during CPB. However, seven control patients but none in the adenosine group required vasodilator treatment (sodium nitroprusside) during CPB to prevent MABP from exceeding 70 mmHg. We conclude that adenosine infusion during CPB in man spares platelets, with minor changes in blood pressure.

[1]  A. Sollevi,et al.  Controlled Hypotension with Adenosine in Cerebral Aneurysm Surgery , 1984, Anesthesiology.

[2]  P Hjemdahl,et al.  Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. , 1984, Acta physiologica Scandinavica.

[3]  C. Zoja,et al.  Dipyridamole Inhibits Platelet Aggregation in Whole Blood , 1983, Thrombosis and Haemostasis.

[4]  D E Oken,et al.  An analysis of glomerular dynamics in rat, dog, and man. , 1982, Kidney international.

[5]  G. Born,et al.  Platelet Antiaggregation And Hemodynamic Effects Of Adenosine And Prostaglandin E1 , 1982, Thrombosis and Haemostasis.

[6]  D. Longmore,et al.  PROSTACYCLIN ADMINISTRATION DURING CARDIOPULMONARY BYPASS IN MAN , 1981, The Lancet.

[7]  B. Fredholm,et al.  The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. , 1981, The Journal of physiology.

[8]  K. Rådegran,et al.  Prostacyclin infusion during cardiopulmonary bypass in man. , 1980, Thrombosis research.

[9]  D. Longmore,et al.  PROSTACYCLIN: A SOLUTION TO SOME PROBLEMS OF EXTRACORPOREAL CIRCULATION Experiments in Greyhounds , 1979, The Lancet.

[10]  J. Humphrey,et al.  INTERNATIONAL UNITS AND STANDARDS , 1976, The Lancet.

[11]  R. Haslam,et al.  Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. , 1975, Molecular pharmacology.

[12]  A. Vander,et al.  Effects of Adenosine Compounds on Renal Function and Renin Secretion in Dogs , 1970, Circulation research.

[13]  A. J. Honour,et al.  Inhibition by Adenosine and by 2-Chloroadenosine of the Formation and Embolization of Platelet Thrombi , 1964, Nature.

[14]  K. Rådegran,et al.  Effects of prostacyclin during cardiopulmonary bypass in man. , 1981, Scandinavian journal of thoracic and cardiovascular surgery.

[15]  R. Colman,et al.  Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. , 1979, The Journal of thoracic and cardiovascular surgery.

[16]  E. Newsholme,et al.  The control of the metabolism and the hormonal role of adenosine. , 1978, Essays in biochemistry.